Drug recall · December 26, 2018
Omnipaque recall
Why: Defective Container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in 10 x 20 mL Vials per carton, Rx only, Distributed by GE Healthcare Inc., Marlborough, MA 01752 U.S.A.; Manufactured by GE Healthcare AS, Oslo, Norway; NDC 0407-1411-20.
- Lots / codes
Lot #: 14301544, Exp 21Sep21
- Quantity
- 1092 cartons
- Company
- GE Healthcare Inc. Life Sciences, Marlborough, MA
- Distribution
- TN
- Initiated
- October 29, 2018 · Voluntary: Firm initiated
- Classified
- December 14, 2018
- Reported
- December 26, 2018
- Ended
- October 30, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.